180 Life Sciences Corp. (NASDAQ: ATNF)
$1.5850
+0.0250 ( +1.60% ) 110.1K
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.
Market Data
Open
$1.5850
Previous close
$1.5600
Volume
110.1K
Market cap
$5.05M
Day range
$1.4960 - $1.6570
52 week range
$1.1600 - $17.7500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-k | Annual reports | 101 | Mar 25, 2024 |
| 8-k | 8K-related | 16 | Mar 14, 2024 |
| 3 | Insider transactions | 1 | Mar 12, 2024 |
| 8-k | 8K-related | 19 | Mar 11, 2024 |
| 3 | Insider transactions | 1 | Mar 11, 2024 |
| 3 | Insider transactions | 1 | Mar 11, 2024 |
| 8-k | 8K-related | 15 | Mar 08, 2024 |
| 8-k | 8K-related | 15 | Mar 01, 2024 |
| 8-k | 8K-related | 16 | Feb 29, 2024 |
| 8-k | 8K-related | 17 | Feb 28, 2024 |